GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Gerresheimer AG (LTS:0NTI) » Definitions » Net Income (Discontinued Operations)

Gerresheimer AG (LTS:0NTI) Net Income (Discontinued Operations) : €0 Mil (TTM As of Aug. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Gerresheimer AG Net Income (Discontinued Operations)?

Net Income (Discontinued Operations) indicates the net income that a firm brought in from operations that will not be used in future reporting periods. Gerresheimer AG's Net Income (Discontinued Operations) for the three months ended in Aug. 2024 was €0 Mil. Its Net Income (Discontinued Operations) for the trailing twelve months (TTM) ended in Aug. 2024 was €0 Mil.

Gerresheimer AG Net Income (Discontinued Operations) Historical Data

The historical data trend for Gerresheimer AG's Net Income (Discontinued Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gerresheimer AG Net Income (Discontinued Operations) Chart

Gerresheimer AG Annual Data
Trend Nov14 Nov15 Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22 Nov23
Net Income (Discontinued Operations)
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Gerresheimer AG Quarterly Data
Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24
Net Income (Discontinued Operations) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Gerresheimer AG Net Income (Discontinued Operations) Calculation

Net Income (Discontinued Operations) indicates the net income that a firm brought in from operations that will not be used in future reporting periods.

Net Income (Discontinued Operations) for the trailing twelve months (TTM) ended in Aug. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gerresheimer AG Net Income (Discontinued Operations) Related Terms

Thank you for viewing the detailed overview of Gerresheimer AG's Net Income (Discontinued Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.

Gerresheimer AG Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Gerresheimer AG (LTS:0NTI) » Definitions » Net Income (Discontinued Operations)
Comparable Companies
XTER:FIE XTER:1SXP XTER:AFX ISRG XPAR:EL BDX TSE:7741 XSWX:ALC RMD TSE:4543 OCSE:COLO B WST COO XSWX:STMN HOLX TSE:7733 XPAR:DIM BAX ALGN AVTR
Traded in Other Exchanges
GRRMY:USA GXId:UK GXI:Germany GXI:Austria
Address
Klaus-Bungert-Strasse 4, Duesseldorf, NW, DEU, 40468
Website
https://www.gerresheimer.com
Gerresheimer AG provides medicine packaging, drug delivery devices, and solutions with a product range for pharma, health, well-being, and biotech. The firm operates in three segments: The plastics and devices segment consists of products for simple and safe drug delivery along with packaging for liquid and solid medicines, The primary packaging glass segment produces glass packaging products for the pharma and cosmetics industries also for food and beverage industry and The advanced technologies segment works on technical and digital solutions to improve the therapy outcome for patients. The company generates the majority of its revenue in Europe, with sales in Germany contributing the major proportion of any country.

Gerresheimer AG Headlines

No Headlines